CPW
IDXX icon

Crestmont Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Crestmont Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$627K Buy
1,115
+70
+7% +$44.9K 0.2% 44
2025
Q4 		$707K Buy
1,045
+15
+1% +$10.2K 0.23% 35
2025
Q3 		$658K Buy
1,030
+122
+13% +$74.1K 0.22% 41
2025
Q2 		$487K Buy
908
+47
+5% +$22.5K 0.18% 46
2025
Q1 		$362K Buy
861
+245
+40% +$106K 0.16% 47
2024
Q4 		$255K Buy
616
+91
+17% +$39.9K 0.11% 56
2024
Q3 		$265K Buy
525
+66
+14% +$32.1K 0.12% 64
2024
Q2 		$224K Buy
+459
New +$230K 0.11% 71

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestmont Private Wealth's IDXX Position: Q1 2026 in Review

Crestmont Private Wealth increased its Idexx Laboratories (IDXX) stake by 6.7% in Q1 2026, buying an estimated $44.9K and bringing the position to 1,115 shares worth $627K. The position accounts for 0.2% of the portfolio, ranked #44.

Crestmont Private Wealth first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $707K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Crestmont Private Wealth held 1,115 shares of Idexx Laboratories worth $627K as of Q1 2026.
  • Crestmont Private Wealth bought 70 Idexx Laboratories shares in Q1 2026, an estimated $44.9K.
  • Idexx Laboratories made up 0.2% of Crestmont Private Wealth's portfolio in Q1 2026, its #44 holding.
  • Crestmont Private Wealth first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
  • Crestmont Private Wealth's Idexx Laboratories position peaked at $707K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Crestmont Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.